1-4 of 4
Kirit M. Ardeshna, MA, MD FRCP, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Procarbazine-Free Escalated Beacopdac in Frontline Therapy of Advanced Hodgkin Lymphoma Reduces Red Cell Transfusion Requirements and May Shorten Time to Menstrual Period Recovery Compared to Escalated Beacopp and Appears to be As Efficacious

Anna Santarsieri, MBBS, Katherine Sturgess, MA, MBBChir, MRCP, MSc, Pauline Brice, Tobias F Menne, MD PhD FRCPath, Wendy Osborne, MD, Thomas Creasey, MBBS, Kirit M. Ardeshna, MA, MD FRCP, FRCPath, Sarah Behan, Stephen Booth, MA,MBBChir,MRCP,FRCPath, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Kate Cwynarski, PhDMD, Sunil Iyengar, MD, Stephen G Jones, Deirdre O'Mahony, MD, Nicolas Martinez-Calle, MD MSc, Pamela McKay, MD, Sateesh K Nagumantry, BM BCh, John Rudge, MA, PhD, Nimish Shah, MD, Gwyneth Stafford, Alexander Sternberg, Benjamin J Uttenthal, MD PhD, Andrew K McMillan, FRCP, George A Follows, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1564.
https://doi.org/10.1182/blood-2019-125256
Published: 2019
Journal Articles

Core Biopsies Performed By Experienced Radiologists and Analysed By Expert Haemato-Pathologists Reliably Permit the Rapid and Safe Diagnosis of Lymphoproliferative Diseases and Negate the Need for Excisional Biopsy in Almost All Patients. Experience from 554 Sequential Core Biopsies from a Single Centre

Oliver C Cohen, MBBS, BSc, FRCPath, Max Brodermann, Aoife Dervin, MBBS, BSc, MRCP, Simon Morley, Ian Proctor, Neel Raja, Kirit M. Ardeshna, MA, MD FRCP, FRCPath, William Townsend, MD FRCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 4746.
https://doi.org/10.1182/blood-2019-123698
Published: 2019
Journal Articles

Phase 2 Results of the iR 2 Regimen (Ibrutinib, Lenalidomide, and Rituximab) in Patients with Relapsed/Refractory (R/R) Non-Germinal Center B Cell-like (Non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

Radhakrishnan Ramchandren, MD, Peter Johnson, MDFRCP, Nilanjan Ghosh, MD PhD, Jia Ruan, MD PhD, Kirit M. Ardeshna, MA, MD FRCP, FRCPath, Roderick Johnson, MD, Gregor Verhoef, MD PhD, David Cunningham, MD FRCP, FMedSci, Sven de Vos, MD PhD, Shireen Kassam, MD, Luis Fayad, MD, John Radford, Sarah Bailly, MD, Fritz Offner, MD, David Morgan, MD, Javier Munoz, MD, Jerry Ping, PhD, Kevin Kwei, PhD, Karl Eckert, BA, Jutta K. Neuenburg, MD PhD, Andre Goy, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 761.
https://doi.org/10.1182/blood-2019-121521
Published: 2019
Journal Articles

Safety and Efficacy of Adct-402 (Loncastuximab Tesirine), a Novel Antibody Drug Conjugate, in Relapsed/Refractory Follicular Lymphoma and Mantle Cell Lymphoma: Interim Results from the Phase 1 First-in-Human Study

Paolo Caimi, MD, Brad S. Kahl, MD, Mehdi Hamadani, MD, Carmelo Carlo-Stella, MD, Shui He, PhD, David Ungar, MD, Jay Feingold, MD PhD, Kirit M. Ardeshna, MA MD FRCP FRCPath, John Radford, MD FRCP, Melhem Solh, MD, Leonard Heffner, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2874.
https://doi.org/10.1182/blood-2018-99-118133
Published: 2018